Catalogue Number: GTX102643-GTX
VEGF antibody detects VEGF protein at cytoplasm in mouse muscle by immunohistochemical analysis. Sample: Paraffin-embedded mouse muscle. VEGF antibody (GTX102643) diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
VEGF antibody detects VEGF protein at cytoplasm in mouse kidney by immunohistochemical analysis. Sample: Paraffin-embedded mouse kidney. VEGF antibody (GTX102643) diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
HepG2 whole cell extract and conditioned medium (30 µg) were separated by 12% SDS-PAGE, and the membrane was blotted with VEGF antibody (GTX102643) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
|Preservative:||0.025% ProClin™ 300|
|Type:||Polyclonal Primary Antibody - Unconjugated|
|Alias:||vascular endothelial growth factor A , MVCD1 , VEGF , VPF|
|Shipping Condition:||Blue Ice|
|Unit(s):||100 ul, 25 ul|
|Immunogen:||Recombinant protein encompassing a sequence within the C-terminus region of human VEGF. The exact sequence is proprietary.|
|Application:||ELISA, IHC-P, WB, IHC|
Description: This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. [provided by RefSeq, Nov 2015]
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption
WB: 1:500-1:3000. IHC-P: 1:100-1:1000. ELISA: Assay dependent. IHC: Assay dependent. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.